Loan Conversion

Summary by AI BETAClose X

Alkemy Capital Investments Plc has announced the conversion of a loan, resulting in the issuance of 56,353 new ordinary shares at £2.40 per share, to satisfy £106,416.66 of principal and £29,100.33 of interest. These new shares are expected to be admitted to trading on the London Stock Exchange on September 8, 2026. Following this issuance, the company's enlarged share capital will comprise 11,243,320 ordinary shares.

Disclaimer*

Alkemy Capital Investments PLC
02 September 2026
 

2 September 2026

 

Alkemy Capital Investments Plc

Loan Conversion

 

Alkemy Capital Investments Plc ("Alkemy" or the "Company") (LSE: ALK) (JV2:FRA) has received a loan conversion notice from the debt facility provider, as set out in the RNS dated 31 July 2025, pursuant to which £106,416.66 of principal and £29,100.33 of interest is being converted at £2.40, resulting in the issue of 56,353 ordinary shares of 2 pence each in the Company ("Ordinary Shares").

The Company will accordingly issue 56,353 new Ordinary Shares in the Company (the "New Ordinary Shares").

 

Admission

Application will be made for the New Ordinary Shares to be admitted to trading on the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange at 8.00 a.m. on 8 September 2026 ("Admission").

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 11,243,320 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Further information

 

For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk.

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

Zeus Capital

Tel: 0203 829 5000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings